Intelligent bio solutions to expand u.s. ip portfolio with expected patent grant

New york, march 20, 2025 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it expects to receive its sixth patent in the united states, which will strengthen the protection of the lateral flow technology core to its intelligent fingerprinting drug testing solution.
inbs Ratings Summary
inbs Quant Ranking